Hamid, Amira H.
HRN: 23-95-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/02/2023
11/05/2023
PO
3.5mL
TID
AGE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes